Accumulation of lopinavir resistance-associated mutations over 3 years follow-up of patients on highly active antiretroviral therapy: implication in salvage therapy

AIDS. 2001 Jun 15;15(9):1183-4. doi: 10.1097/00002030-200106150-00016.

Authors

K Tsuchiya¹, S Matsuoka, A Hachiya, A Yasuoka, N Tachikawa, Y Kikuchi, I Genka, K Teruya, S Kimura, S Oka

Affiliation

¹ AIDS Clinical Center, International Medical Center of Japan, Tokyo.

PMID: 11416723
DOI: 10.1097/00002030-200106150-00016

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antiretroviral Therapy, Highly Active
Drug Resistance, Microbial
Follow-Up Studies
HIV Infections / drug therapy
HIV Infections / virology*
HIV Protease Inhibitors / pharmacology
HIV Protease Inhibitors / therapeutic use*
HIV-1 / drug effects*
HIV-1 / genetics
Humans
Lopinavir
Mutagenesis
Pyrimidinones / pharmacology
Pyrimidinones / therapeutic use*
Retrospective Studies
Salvage Therapy
Time Factors

Substances

HIV Protease Inhibitors
Pyrimidinones
Lopinavir